351 related articles for article (PubMed ID: 9737396)
1. Quality of biotechnological products: viral safety evaluation of biotechnology products derived from cell lines of human or animal origin. ICH Harmonised Tripartite Guideline.
Dev Biol Stand; 1998; 93():177-201. PubMed ID: 9737396
[No Abstract] [Full Text] [Related]
2. Quality of biotechnological products: analysis of the expression construct in cell lines used for production of r-DNA derived protein products. ICH Harmonised Tripartite Guideline.
Dev Biol Stand; 1998; 93():205-8. PubMed ID: 9737397
[No Abstract] [Full Text] [Related]
3. Quality of biotechnological products: derivation and characterisation of cell substrates used for production of biotechnological/biological products. ICH Harmonised Tripartite Guideline.
Dev Biol Stand; 1998; 93():223-34. PubMed ID: 9737399
[No Abstract] [Full Text] [Related]
4. Quality of biotechnological products: stability testing of biotechnological/biological products. Annex to the ICH Harmonised Tripartite Guideline for the Stability Testing of New Drug Substances and Products.
Dev Biol Stand; 1998; 93():211-9. PubMed ID: 9737398
[No Abstract] [Full Text] [Related]
5. International Conference on Harmonisation; guidance on viral safety evaluation of biotechnology products derived from cell lines of human or animal origin; availability--FDA. Notice.
Fed Regist; 1998 Sep; 63(185):51074-84. PubMed ID: 10185809
[TBL] [Abstract][Full Text] [Related]
6. WHO requirements for the use of animal cells as in vitro substrates for the production of biologicals (requirements for biological substances No 50).
Dev Biol Stand; 1998; 93():141-71. PubMed ID: 9737395
[No Abstract] [Full Text] [Related]
7. Safety of biological products prepared from mammalian cell culture. In-process testing for viral agents.
Dev Biol Stand; 1998; 93():130-1. PubMed ID: 9737389
[No Abstract] [Full Text] [Related]
8. Issues related to harmonization of testing requirements for viral safety.
Hayakawa T
Dev Biol Stand; 1996; 88():15-8. PubMed ID: 9119129
[TBL] [Abstract][Full Text] [Related]
9. Safety of biological products prepared from mammalian cell culture. Detecting viruses in cell banks.
Dev Biol Stand; 1998; 93():129. PubMed ID: 9737388
[No Abstract] [Full Text] [Related]
10. International Conference on Harmonisation; guidance on quality of biotechnological/biological products: derivation and characterization of cell substrates used for production of biotechnological/biological products; availability. Notice. Food and Drug Administration, HHS.
Fed Regist; 1998 Sep; 63(182):50244-9. PubMed ID: 12269373
[TBL] [Abstract][Full Text] [Related]
11. Viral safety of biological products and the concept of validation.
Horaud F
Dev Biol Stand; 1996; 88():19-24. PubMed ID: 9119135
[No Abstract] [Full Text] [Related]
12. Process scale considerations in evaluation studies and scale-up.
Walter JK; Werz W; Berthold W
Dev Biol Stand; 1996; 88():99-108. PubMed ID: 9119169
[TBL] [Abstract][Full Text] [Related]
13. Survey of manufacturers and developers of cell culture-derived products for evidence of adventitious contamination.
Lubiniecki AS
Dev Biol Stand; 1996; 88():195-7. PubMed ID: 9119136
[No Abstract] [Full Text] [Related]
14. Safety issues of animal products used in serum-free media.
Merten OW
Dev Biol Stand; 1999; 99():167-80. PubMed ID: 10404888
[TBL] [Abstract][Full Text] [Related]
15. Relationship between nature and source of risk and process validation.
Berthold W; Werz W; Walter JK
Dev Biol Stand; 1996; 88():59-71. PubMed ID: 9119164
[No Abstract] [Full Text] [Related]
16. Current good tissue practice for human cell, tissue, and cellular and tissue-based product establishments; inspection and enforcement. Final rule.
Food and Drug Administration, HHS
Fed Regist; 2004 Nov; 69(226):68611-88. PubMed ID: 15562555
[TBL] [Abstract][Full Text] [Related]
17. European Regulatory guidance on virus safety of recombinant proteins, monoclonal antibodies and plasma derived medicinal products.
Celis P; Silvester G
Dev Biol (Basel); 2004; 118():3-10. PubMed ID: 15645667
[TBL] [Abstract][Full Text] [Related]
18. Safety of biological products prepared from mammalian cell culture. Testing source materials.
Dev Biol Stand; 1998; 93():131-3. PubMed ID: 9737390
[No Abstract] [Full Text] [Related]
19. ICH guidelines and PhEur monographs on derivation and characterisation of cell substrates used for production of biotechnological/biological products. International Conference on Harmonisation.
Dobbelaer R
Dev Biol Stand; 1999; 98():159-65; discussion 167. PubMed ID: 10494969
[TBL] [Abstract][Full Text] [Related]
20. Animal virus contaminants of biotechnology products.
Onions D
Dev Biol (Basel); 2004; 118():155-63. PubMed ID: 15645686
[No Abstract] [Full Text] [Related]
[Next] [New Search]
